Title : Crizotinib for ROS1-rearranged lung cancer and pulmonary tumor thrombotic microangiopathy under venoarterial extracorporeal membrane oxygenation.

Pub. Date : 2022 Jan

PMID : 35506104






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Crizotinib for ROS1-rearranged lung cancer and pulmonary tumor thrombotic microangiopathy under venoarterial extracorporeal membrane oxygenation. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
2 Crizotinib, an oral tyrosine kinase inhibitor targeting anaplastic lymphoma kinase, MET, and ROS1 kinase domains dramatically resolved PH, resulting in more than 3 years of survival. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens